Skip to main content
Premium Trial:

Request an Annual Quote

Peter Gwynne, John T. Carr, Karen Young Kreeger, Bill Oldendorf


A freelance writer based on Cape Cod, Peter Gwynne, “How Millennium Makes the Most of Microarrays” p. 20, writes about science, technology, and medicine. A former science editor of Newsweek, he has started up scientific magazines in the US, Europe, and Asia. Peter has won numerous awards and has taught science writing at Boston University, MIT, and New York University.

John T. Carr, “Biotech Buys into Bioinformatics,” p. 27, is a freelance writer in New York City. John has covered Capitol Hill for Bloomberg Business News, published articles in an assortment of medical trade magazines, and forayed to “the other side of the fence” as a strategic consultant for medical startups. His first feature-length screenplay, “Alive at Dawn,” will begin filming in New York in the spring of 2000.

Karen Young Kreeger, “Champion of the Plant Kingdom,” p. 40, says her interview with Kellye Eversole changed her opinion of lobbyists. Kreeger is a freelance science and medical writer for trade and consumer magazines who lives in Ridley Park, Pa. Her book, “Guide to Nontraditional Careers in Science,” was published last year by Taylor & Francis, Philadelphia.

Having started his career writing for medical research centers about “sometimes abstruse research,” Bill Oldendorf, “Democratizers of the DNA Microarray,” p. 32, says he is now enjoying learning about the business side of healthcare and how science translates into the marketplace. He is a freelance writer in Sherman Oaks, Calif., where he wears lots of sunscreen and (when he’s not in front of the computer) enjoys hiking and music.

The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.